Global Radiodermatitis Market: Industry Analysis and Forecast (2020-2026) By Product, Distribution Channel and Region

Global Radiodermatitis Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 4.2% during forecast period.

Global Radiodermatitis Market Overview:

Radiodermatitis is a cutaneous reaction that occurs as a result of irradiation used to treat cancer. Radiodermatitis affects the majority of cancer patients at some point during or after their treatment with radiation. Dry papery skin, pigmentation, peeling, skin rash, and lesions are common symptoms of this illness.

Global Radiodermatitis Market Dynamics:

Growing prevalence of cancer patients is the major factor driving the market growth. The rise in the prevalence of cancer and the usage of irradiation for treatment is driving the worldwide radiodermatitis market forward. Furthermore, the growing geriatric population propels the radiodermatitis market forward. Radiodermatitis has become more common as a result of enhanced radiation therapy techniques due to improved quality assurance and consistency in treatment regimens across many facilities. According to the MMR study, more than half of individuals who receive radiotherapy develop radiodermatitis at some time throughout their treatment. According to estimates, more than 14 million new instances of cancer are diagnosed worldwide each year, and radiation treatment (RT) has the potential to enhance cure rates for 3.5 million people while also providing calming respite and curing a larger population. Low-level light treatment is often used to treat radiation dermatitis. Furthermore, market growth is likely to be aided by the R&D of new medicines for the treatment of radiodermatitis. Kannalife, Inc., for example, filed a new U.S. Patent in December 2019 for its patented and innovative CBD-like compounds for the treatment of radiodermatitis and other skin conditions. The growing number of clinical studies being done to assess the efficacy of a wide range of radiodermatitis therapy solutions is expected to extend the product pipeline and provide attractive growth prospects for the market. The global radiodermatitis market is projected to be hampered by the introduction of better radiation therapy equipment. The severity and likelihood of developing radiodermatitis might be determined by the patient or the treatment. The type and quality of the radiation beam, as well as the location and size of the treatment field, are all therapy-related criteria. By more precisely targeting tumours, modern radiotherapy treatments such as intensity-modulated radiation therapy (IMRT) and proton treatment can reduce the incidence of radiodermatitis. Such a scenario is likely to stifle market growth. Furthermore, high-cost dressings such as honey-impregnated and silicone dressings are projected to restrain the market growth. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Radiodermatitis Market Segment Analysis:

The Global Radiodermatitis Market is segmented on the basis of Product and Distribution Channel. Based on Product, the Topical segment dominated the global market in 2019 by gaining a market share of up to 70%. The benefits associated with topical products are thought to account for a large portion of the market. These advantages include ease of use, availability, and high cost-effectiveness, all of which are expected to be important contributors in the adoption of these goods in the next years. Topical treatments also protect the skin from abrasive materials and limit the risk of germ transmission. Some of the most common products in this category are corticosteroids, hydrophilic creams, and topical antibiotics. As a result of its status as a gold standard in the treatment of inflammatory skin disorders, corticosteroids accounted for the biggest share of topical medications, supporting their use in the treatment of Radiodermatitis. Global Radiodermatitis Market To know about the Research Methodology :- Request Free Sample Report

Global Radiodermatitis Market Regional Insights:

Global Radiodermatitis Market Regional InsightsAsia Pacific is expected to dominate the global market during forecast period. The Asia Pacific commanded the majority share of the market. The growing number of cancer patients in this region is a major contribution to the region's large proportion of the market. Furthermore, the increased share acquired by this region is due to substantial collaborations made by important businesses in order to increase their product range growth capabilities. Also, established pharmaceutical businesses in this region are heavily involved in the commercialization of their medications as well as the promotion of their use by end consumers. Favourable government efforts that encourage research operations, as well as an increase in outsourcing by industrialized nations, are driving forces for this region's growth. Due to rising obesity rates and the presence of a large cancer patient pool, India is expected to see considerable growth in the next years, fuelling demand for radiation dermatitis products in the Asia Pacific region. The report also helps in understanding Global Radiodermatitis Market dynamics, structure by analyzing the market segments and project the Global Radiodermatitis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Radiodermatitis Market make the report investor’s guide.

Global Radiodermatitis Market Scope: Inquire before buying

Global Radiodermatitis Market

Global Radiodermatitis Market, By Region:

• North America • Europe • South America • MEA • APAC

Global Radiodermatitis Market, Key players:

• Stratpharma AG • Smith & Nephew plc • Molnlycke Health Care AB • Derma Sciences Inc. • ConvaTec Inc. • BMG PHARMA S.p.A. • Acelity L.P. Inc. • Alliqua BioMedical. • InterMed • 3M Healthcare • Bausch Health Companies Inc • Bayer Ag • Glaxosmithkline Plc • Helsinn Healthcare SA • Mylan N.V.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Radiodermatitis Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Radiodermatitis Market 3.4. Geographical Snapshot of the Radiodermatitis Market, By Manufacturer share 4. Global Radiodermatitis Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Radiodermatitis Market 5. Supply Side and Demand Side Indicators 6. Global Radiodermatitis Market Analysis and Forecast, 2019-2026 6.1. Global Radiodermatitis Market Size & Y-o-Y Growth Analysis. 7. Global Radiodermatitis Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 7.1.1. Topical 7.1.2. Corticosteroids 7.1.3. Hydrophilic Creams 7.1.4. Antibiotics 7.1.5. Hydrogel & Hydrocolloid 7.1.6. Silicone Coated 7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 7.2.1. Hospital Pharmacies 7.2.2. Retail Pharmacies 7.2.3. Online Pharmacies 8. Global Radiodermatitis Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Radiodermatitis Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 9.1.1. Topical 9.1.2. Corticosteroids 9.1.3. Hydrophilic Creams 9.1.4. Antibiotics 9.1.5. Hydrogel & Hydrocolloid 9.1.6. Silicone Coated 9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 9.2.1. Hospital Pharmacies 9.2.2. Retail Pharmacies 9.2.3. Online Pharmacies 10. North America Radiodermatitis Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Radiodermatitis Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 12. Canada Radiodermatitis Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 13. Mexico Radiodermatitis Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 14. Europe Radiodermatitis Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 15. Europe Radiodermatitis Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Radiodermatitis Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 17. France Radiodermatitis Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 18. Germany Radiodermatitis Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 19. Italy Radiodermatitis Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 20. Spain Radiodermatitis Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 21. Sweden Radiodermatitis Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 22. CIS Countries Radiodermatitis Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 23. Rest of Europe Radiodermatitis Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 24. Asia Pacific Radiodermatitis Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 25. Asia Pacific Radiodermatitis Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Radiodermatitis Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 27. India Radiodermatitis Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 28. Japan Radiodermatitis Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 29. South Korea Radiodermatitis Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 30. Australia Radiodermatitis Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 31. ASEAN Radiodermatitis Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 32. Rest of Asia Pacific Radiodermatitis Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 33. Middle East Africa Radiodermatitis Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 34. Middle East Africa Radiodermatitis Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Radiodermatitis Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 36. GCC Countries Radiodermatitis Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 37. Egypt Radiodermatitis Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 38. Nigeria Radiodermatitis Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 39. Rest of ME&A Radiodermatitis Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 40. South America Radiodermatitis Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 41. South America Radiodermatitis Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Radiodermatitis Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 43. Argentina Radiodermatitis Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 44. Rest of South America Radiodermatitis Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Radiodermatitis Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Stratpharma AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Smith & Nephew plc 45.3.3. Molnlycke Health Care AB 45.3.4. Derma Sciences Inc. 45.3.5. ConvaTec Inc. 45.3.6. BMG PHARMA S.p.A. 45.3.7. Acelity L.P. Inc. 45.3.8. Alliqua BioMedical. 45.3.9. InterMed 45.3.10. 3M Healthcare 45.3.11. Bausch Health Companies Inc 45.3.12. Bayer Ag 45.3.13. Glaxosmithkline Plc 45.3.14. Helsinn Healthcare SA 45.3.15. Mylan N.V. 46. Primary Key Insights

About This Report

Report ID105944
Category Healthcare
Published DateJun 2021
Updated Date
Contact Us